Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

View source ↗

Summary

A clinical trial update examining how immune checkpoint inhibitors and other immunotherapies may drive tumor evolution through treatment-induced selection press…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Head and Neck Cancer, Melanoma | Status: ACTIVE_NOT_RECRUITING